McGovern Researchers Lead Long-Term COVID-19 Study
A UTHealth COVID-19 ARDS Research Team, led by Ben Bobrow, MD (Chairman Emergency Medicine Department, and the Texas Emergency Medicine Research Center’s translational research team) in conjunction with researchers from the laboratories of Xiaoyi Yuan, PhD, Marie-Francoise Doursout, PhD, and Holger K. Eltzschig, MD, PhD are conducting a long-term study on the impact of COVID-19 and the effect of the activator of hypoxia inducible factor “vadadustat,” on organ injury and overall recovery. This two year study will follow patients to better understand COVID-19 and how to help people fully recover while minimizing deaths. To date, the study has enrolled over 449 patients at four Memorial Hermann Hospitals and Lyndon B. Johnson Hospital.
Key researchers in both department include:
- Nabras Abdulrahman, MS
- Emily Ayub, MD
- Bentley J. Bobrow, MD
- Alfredo Castellano, MBBS
- Marie-Francoise Doursout, PhD
- Holger K. Eltzschig, MD, PhD
- Misha Granado, MPH, MS
- Charles Green, PhD
- Victor Guaregua, BS
- Ashley Holt, BSN
- Synthea Horton, BS
- Elizabeth Jones, MD
- Benjamin Karfunkle, MD
- Marium Kaukab, MS
- Katheryn Larimore, MD
- Samuel Luber, MD
- Marka Lyons, MS
- Talha Mubashir, MD
- Katelyn Oliver, BSN
- Misty Ottman, RN, BS
- Gordon Richard, MD
- David Robinson, MD
- Neomi Sepulveda, BS
- Paulina Sergot, MD
- Charles Southwell, BS
- Yanyu Wang, PhD
- George Williams, MD
- Xiaoyi Yuan, PhD
Congratulations to everyone on this joint venture.
More information can be found at:
McGovern researchers lead long-term COVID-19 study at McGovern Medical School (uth.edu)